Key result
A clinical risk score using CRT device diagnostics successfully classified patients into low (2.8%), moderate (10.1%), and high (13.4%) risk of death.
Why the study?
Can measured diagnostic variables in CRT devices predict mortality in patients receiving cardiac resynchronization therapy?
Population
1,274 patients receiving cardiac resynchronization therapy from two studies: CRT RENEWAL and HF-HRV
Design
Cohort
Authors
Loading...
May support device-based risk stratification in CRT recipients; hypothesis-generating pending prospective validation.
Cohort (n=1,274)
Can measured diagnostic variables in CRT devices predict mortality in patients receiving cardiac resynchronization therapy?
Diagnostic variables measured by CRT devices can be used to create a validated clinical risk score that effectively predicts mortality in patients receiving cardiac resynchronization therapy.
Singh et al. (2009) conducted a cohort in Heart failure requiring cardiac resynchronization therapy (n=1,274). Device diagnostics risk model was evaluated on Mortality. A clinical risk score using CRT device diagnostics successfully classified patients into low (2.8%), moderate (10.1%), and high (13.4%) risk of death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: